Home
Conditions
Blood Protein Disorders

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,039 public trials 566 recruiting studies

Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation

NCT01283776

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations: University of Cologne Cologne, Germany

View Trial Details

Completed

Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia

NCT00142116

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT00075881

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Eastern Cooperative Oncology Group Boston, Massachusetts, United States

View Trial Details

Completed

Sunitinib in Treating Patients With Relapsed Multiple Myeloma

NCT00514137

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Mayo Clinic Cancer Research Consortium Rochester, Minnesota, United States

View Trial Details

Completed

Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma

NCT00054639

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +60 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

NCT00290472

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Burkitt Lymphoma, +54 more
Locations: University of Chicago Chicago, Illinois, United States

Decatur Memorial Hospital Decatur, Illinois, United States

Evanston Hospital CCOP Evanston, Illinois, United States

Ingalls Memorial Hospital Harvey, Illinois, United States

View all 13 locations

View Trial Details

Completed

A Study of Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma

NCT00872521

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Adelaide, Australia

Box Hill, Australia

Brisbane, Australia

Camperdown, Australia

View all 16 locations

View Trial Details

Completed

An Efficacy and Safety Study of Siltuximab in Participants With Relapsed or Refractory Multiple Myeloma

NCT00402181

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Duarte, California, United States

Norwalk, Connecticut, United States

Indianapolis, Indiana, United States

Rochester, Minnesota, United States

View all 13 locations

View Trial Details

Completed

An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple Myeloma

NCT00431769

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Graz, Austria

Oberpullendorf, Austria

Vienna, Austria

Antwerp, Belgium

View all 38 locations

View Trial Details

Completed

Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma

NCT00743288

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Comprehensive Blood and Cancer Center Bakersfield, California, United States

James R. Berenson MD, Incorporated West Hollywood, California, United States

Rocky Mountain Cancer Centers - Denver Midtown Denver, Colorado, United States

Center for Cancer and Blood Disorders Bethesda, Maryland, United States

View Trial Details

Blood Protein Disorders

Blood Protein Disorders trial results

Related conditions